Biomaterial Database

In vitro activity of flurithromycin against some genital pathogens. 1991

P M Furneri, and G Tempera, and A M Lepore, and C Bonfanti, and G Nicoletti

Institute of Microbiology, University of Catania, Italy.

The in vitro antibacterial activity of a new macrolide drug, flurithromycin, was evaluated in comparison with the activity of erythromycin A against some genital pathogens. The strains tested, C. trachomatis, U. urealyticum. M. hominis, N. gonorrhoeae, S. agalactiae and M. genitalium, were both clinically isolates and ATCC standards. The evidenced activity of flurithromycin is similar to that of erythromycin A. Resistances with both macrolides were found in all M. hominis strains and in one strain of U. urealyticum. No particular differences are exhibited between clinical and standard microorganisms.

UI	MeSH Term	Description	Entries
D008826	Microbial Sensitivity Tests	Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses).	Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D009174	Mycoplasma	A genus of gram-negative, mostly facultatively anaerobic bacteria in the family MYCOPLASMATACEAE. The cells are bounded by a PLASMA MEMBRANE and lack a true CELL WALL. Its organisms are pathogens found on the MUCOUS MEMBRANES of humans, ANIMALS, and BIRDS.	Eperythrozoon,Haemobartonella,Mycoplasma putrefaciens,PPLO,Pleuropneumonia-Like Organisms,Pleuropneumonia Like Organisms
D009344	Neisseria gonorrhoeae	A species of gram-negative, aerobic bacteria primarily found in purulent venereal discharges. It is the causative agent of GONORRHEA.	Diplococcus gonorrhoeae,Gonococcus,Gonococcus neisseri,Merismopedia gonorrhoeae,Micrococcus der gonorrhoe,Micrococcus gonococcus,Micrococcus gonorrhoeae
D002692	Chlamydia trachomatis	Type species of CHLAMYDIA causing a variety of ocular and urogenital diseases.
D003470	Culture Media	Any liquid or solid preparation made specifically for the growth, storage, or transport of microorganisms or other types of cells. The variety of media that exist allow for the culturing of specific microorganisms and cell types, such as differential media, selective media, test media, and defined media. Solid media consist of liquid media that have been solidified with an agent such as AGAR or GELATIN.	Media, Culture
D004352	Drug Resistance, Microbial	The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS).	Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D004917	Erythromycin	A bacteriostatic antibiotic macrolide produced by Streptomyces erythreus. Erythromycin A is considered its major active component. In sensitive organisms, it inhibits protein synthesis by binding to 50S ribosomal subunits. This binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins.	Erycette,Erymax,Erythromycin A,Erythromycin C,Erythromycin Lactate,Erythromycin Phosphate,Ilotycin,T-Stat,Lactate, Erythromycin,Phosphate, Erythromycin,T Stat,TStat
D006207	Half-Life	The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity.	Halflife,Half Life,Half-Lifes,Halflifes
D001419	Bacteria	One of the three domains of life (the others being Eukarya and ARCHAEA), also called Eubacteria. They are unicellular prokaryotic microorganisms which generally possess rigid cell walls, multiply by cell division, and exhibit three principal forms: round or coccal, rodlike or bacillary, and spiral or spirochetal. Bacteria can be classified by their response to OXYGEN: aerobic, anaerobic, or facultatively anaerobic; by the mode by which they obtain their energy: chemotrophy (via chemical reaction) or PHOTOTROPHY (via light reaction); for chemotrophs by their source of chemical energy: CHEMOLITHOTROPHY (from inorganic compounds) or chemoorganotrophy (from organic compounds); and by their source for CARBON; NITROGEN; etc.; HETEROTROPHY (from organic sources) or AUTOTROPHY (from CARBON DIOXIDE). They can also be classified by whether or not they stain (based on the structure of their CELL WALLS) with CRYSTAL VIOLET dye: gram-negative or gram-positive.	Eubacteria

Related Publications

P M Furneri, and G Tempera, and A M Lepore, and C Bonfanti, and G Nicoletti

Comparative in-vitro activity of sparfloxacin against genital pathogens.

May 1996, The Journal of antimicrobial chemotherapy,

P M Furneri, and G Tempera, and A M Lepore, and C Bonfanti, and G Nicoletti

Comparative antimicrobial activity of the new macrolide flurithromycin against respiratory pathogens.

February 1988, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology,

P M Furneri, and G Tempera, and A M Lepore, and C Bonfanti, and G Nicoletti

In vitro activity of dermaseptin S1 derivatives against genital pathogens.

September 2010, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica,

P M Furneri, and G Tempera, and A M Lepore, and C Bonfanti, and G Nicoletti

In vitro activity of dermaseptin S4 derivatives against genital infections pathogens.

April 2008, Regulatory toxicology and pharmacology : RTP,

P M Furneri, and G Tempera, and A M Lepore, and C Bonfanti, and G Nicoletti

A review of the in-vitro activity of roxithromycin against genital pathogens.

November 1987, The Journal of antimicrobial chemotherapy,

P M Furneri, and G Tempera, and A M Lepore, and C Bonfanti, and G Nicoletti

In-vitro activity of fleroxacin against urinary tract and genital tract pathogens.

October 1988, The Journal of antimicrobial chemotherapy,